4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Biodexa Pharmaceuticals Plc (BDRX) operates in the Biotechnology industry and is headquartered in Cardiff, United Kingdom with about 11 employees. Its market capitalization is roughly $1 million. In the fiscal year ended 2025-12-31, BDRX reported £0M in revenue and (£6M) in net income.
Biodexa Pharmaceuticals Plc, a clinical stage biopharmaceutical company, focuses on developing a pipeline of products for the treatment of familial adenomatous polyposis, non-muscle invasive bladder cancer, and Type 1 diabetes and rare/orphan brain cancer.
Interactive charts & full statements →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue | £0M | £0M | £0M | £1M | — |
| Gross Profit | (£4M) | (£5M) | (£4M) | (£4M) | — |
| Operating Income (EBIT) | (£9M) | (£9M) | (£8M) | (£9M) | — |
| Net Income | (£6M) | (£6M) | (£7M) | (£8M) | — |
GBP; £M / £B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Cash flow | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Dividends Paid | £0M | £0M | £0M | £0M | — |
GBP; £M / £B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | £18M | £15M | £10M | £6M | — |
| Total Liabilities | £7M | £6M | £6M | £2M | — |
GBP; £M / £B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive BDRX viewer.
About TickerBase · Data methodology & sources · Privacy · Terms